Composition, dosage form and associated dietary supplement to support women in menopause and / or perimenopause
DE202025004171U1Active Publication Date: 2026-05-21EPIGENICS GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- DE · DE
- Patent Type
- Utility models
- Current Assignee / Owner
- EPIGENICS GMBH
- Filing Date
- 2025-04-25
- Publication Date
- 2026-05-21
Abstract
Composition including: a) Calcium citrate containing up to 1.2 g of calcium; b) Red maca powder up to 2.4 g; c) Sage leaf extract up to 1.8 g; d) Hop cone extract up to 1.8 g; e) Milk thistle seed extract up to 1.5 g; f) Chaste tree extract up to 1 g; g) Vitamin E up to 120 mg; h) Vitamin B5 up to 60 g; i) Vitamin B6 up to 14 mg; j) Vitamin B2 up to 14 mg; k) Vitamin B1 up to 11 mg; l) Vitamin B9 up to 2 mg; m) Biotin up to 400 µg; and n) Vitamin B12 up to 40 µg.
Need to check novelty before this filing date? Find Prior Art